Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6054_Библиотеки_им_академика_М_И_Перельмана.pdf
DePaula, A. L., Macedo, A. L. V., Rassi, N., Vencio, S., Machado, C. A., Mota, B. R.,
Silva, L. Q., Halpern, A., & Schraibman, V. (2008). Laparoscopic treatment of
metabolic syndrome in patients with type 2 diabetes mellitus. Surgical Endoscopy,
22(12), 2670–2678.
Dirksen, C., Damgaard, M., Bojsen-Møller, K. N., Jørgensen, N. B., Kielgast, U.,
Jacobsen, S. H., Naver, L. S., Worm, D., Holst, J. J., Madsbad, S., Hansen, D. L., &
Madsen, J. L. (2013). Fast pouch emptying, delayed small intestinal transit, and
exaggerated gut hormone responses after Roux-en-Y gastric bypass.
Neurogastroenterology and Motility, 25(4), 255–346.
Grueneberger, J. M., Fritz, T., Zhou, C., Meyer, S., Karcz-Socha, I., Sawczyn, T.,
Stygar, D., Goos, M., Hopt, U. T., & Küsters, S. (2013). Long segment ileal
transposition leads to early amelioration of glucose control in the diabetic obese Zucker
rat. Wideochirurgia i Inne Techniki Mało Inwazyjne, 8(2), 130–138.
Hindsø, M., Bojsen-Møller, K. N., Kristiansen, V. B., Holst, J. J., van Hall, G., &
Madsbad, S. (2022). Early effects of Roux-en-Y gastric bypass on dietary fatty acid
absorption and metabolism in people with obesity and normal glucose tolerance.
International Journal of Obesity, 46(7), 1359–1365.
Kindel, T. L., Yoder, S. M., Seeley, R. J., D’Alessio, D. A., & Tso, P. (2009).
Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, goto-kakizaki
rat by a GLP-1 receptor-mediated mechanism. Journal of Gastrointestinal Surgery,
13(10), 1762–1772.
Martinussen, C., Bojsen-Møller, K. N., Dirksen, C., Svane, M. S., Kristiansen, V. B.,
Hartmann, B., Holst, J. J., & Madsbad, S. (2019). Augmented GLP-1 secretion as seen
after gastric bypass may be obtained by delaying carbohydrate digestion. Journal of
Clinical Endocrinology and Metabolism, 104(8), 3233–3244.
Odstrcil, E. A., Martinez, J. G., Santa Ana, C. A., Xue, B., Schneider, R. E., Steffer, K.
J., Porter, J. L., Asplin, J., Kuhn, J. A., & Fordtran, J. S. (2010). The contribution of
malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y
gastric bypass. American Journal of Clinical Nutrition, 92(4), 704–713.
Patriti, A., Facchiano, E., Annetti, C., Aisa, M. C., Galli, F., Fanelli, C., & Donini, A.
(2005). Early improvement of glucose tolerance after ileal transposition in a non-obese
type 2 diabetes rat model. Obesity Surgery, 15(9), 1258–1264.
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A.,
Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., & Kashyap, S. R. (2017).
Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. New
England Journal of Medicine, 376(7), 641–651.
Tan, T., Behary, P., Tharakan, G., Minnion, J., Al-Najim, W., Albrechtsen, N. J. W.,
Holst, J. J., & Bloom, S. R. (2017). The effect of a subcutaneous infusion of GLP-1,
OXM, and PYY on energy intake and expenditure in obese volunteers. Journal of
Clinical Endocrinology and Metabolism, 102(7), 2364–2372.
SOME MUSCLES DO MORE FOR YOUR METABOLIC HEALTH THAN
OTHERS
Hamilton, M. T., Hamilton, D. G., & Zderic, T. W. (2022). A potent physiological
method to magnify and sustain soleus oxidative metabolism improves glucose and lipid
regulation. iScience, 25(9), 104869.
ABOUT THE OTHER WEIGHT-LOSS HORMONES
Al-Massadi, O., Fernø, J., Diéguez, C., Nogueiras, R., & Quiñones, M. (2019).
Glucagon control on food intake and energy balance. International Journal of
Molecular Sciences, 20(16), 3905.
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Da kin, C. L.,
Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., Cone, R. D., & Bloom, S. R.
(2002). Gut hormone PYY (3–36) physiologically inhibits food intake. Nature
(London), 418(6898), 650–654.
Butler, P. C., Chou, J., Carter, W. B., Wang, Y. N., Bu, B. H., Chang, D., Chang, J. K., &
Rizza, R. A. (1990). Effects of meal ingestion on plasma amylin concentration in
NIDDM and nondiabetic humans. Diabetes (New York, N.Y.), 39(6), 752–756.
Degen, L., Oesch, S., Casanova, M., Graf, S., Ketterer, S., Drewe, J., & Beglinger, C.
(2005). Effect of peptide YY3–36 on food intake in humans. Gastroenterology (New
York, N.Y. 1943), 129(5), 1430–1436.
Karra, E., Chandarana, K., & Batterham, R. L. (2009). The role of peptide YY in
appetite regulation and obesity. Journal of Physiology, 587(1), 19–25.
Kirkham, T. C., & Harrold, J. A. (2008) The anorectic peptide PYY (3-36) reduces the
reinforcing efficacy of food in free-feeding rats. Journal of Psychopharmacology,
22(1), 34–41.
Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015). Amylin:
pharmacology, physiology, and clinical potential. Pharmacological Reviews, 67(3),
564–600.
Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017).
The new biology and pharmacology of glucagon. Physiological Reviews, 97(2), 721–
766.
Pocai, A., Carrington, P. E., Liu, F., Miller, C., Tota, L. M., Gaochao Zhou, Xiaoping
Zhang, Sountis, M. M., Santoprete, A., Capito, E., Chicchi, G. G., Thornberry, N.,
Adams, J. R., Bianchi, E., Pessi, A., Marsh, D. J., Sinharoy, R., Wright, M., Eiermann,
G., & Jiang, G. (2009). Glucagon-like peptide 1/glucagon receptor dual agonism
reverses obesity in mice. Diabetes (New York, N.Y.), 58(10), 2258–2266.
THE CLAIM THAT “LASTING WEIGHT LOSS IS ALMOST IMPOSSIBLE”
Clemmensen, C. & Sjøgren, K. (2020) Forskere jagter årsagen til det vanskelige
vedvarende vægttab. Sciencenews/Sciencenews.dk.
https://sciencenews.dk/da/forskere-jagter-aarsagen-til-det-vanskelige-vedvarende-
vaegttab.
Jensen, S. L. (2024). He has been researching obesity for more than fifty years. He
knows the best possible way to avoid having overweight children. Berlingske
Tidende/Berlingske.dk. jttp://www.berlingske.dk/indland/han-har-forsket-i-fedme-i-
mere-end-50-aar-han-ved-hvordan-du-bedst-muligt?.
Poulsen, A. G. (2021). Ny rapport om forebyggelse af overvægt: vi skal tænke det hele
om. Ugeskriftet/Ugeskriftet.dk. https://ugeskriftet.dk/nyhed/ny-rapport-om-forebyggelse-
af-overvaegt-vi-skal-taenke-det-hele-om.
Ringgaard, A. (2020). Forskere: Overvægt er sjældent selvforskyldt. Videnskab
DK/Videnskab.dk. https://videnskab.dk/krop-sundhed/forskere-overvaegt-er-sjaeldent-
selvforskyldt/.
Videnskaben bag overvægt/Truth About Weight Global.
https://www.truthaboutweight.global/dk/da/videnskab.html.
BOOKS CONTAINING MORE OF THE SAME
Holst, J. J. (2024). Historien om GLP-1: en forskningshistorisk rejse i behandlingen af
diabetes og svær overvægt. FADL.
Sams, A. (2017). Sandheden om sukker—alt, du skal vide om sukker for at opnå solid
sundhed, undgå inflammation, smid kiloene og styr uden om livsstilssygdomme.
Gyldendal.
Sams, A. (2019). The truth about sugar—avoid inflammation, drop pounds and steer
clear of lifestyle diseases. Gyldendal.
Sams, A., & Faerber, J. (2022). Kålhydrater—Gør kål på overvægt, insulinresistens og
sukkertrang. Gyldendal.
About the author
ANETTE SAMS (1971) is a pharmacist with a PhD from the University of
Copenhagen.
After fifteen years as a medical researcher, manager, and director at Novo Nordisk,
Anette Sams left her job to enlighten Danes about the body’s own biological “health
switches” that can help combat obesity, unwanted inflammation, and lifestyle diseases.
Among other things, this has led to four best-selling books, including one that has
previously been translated into English, namely The Truth About Sugar, published by
Gyldendal.
Alongside her work as an author and health advocate, Anette Sams works for a
company developing new treatments for serious cardiovascular diseases.
W
at’s next on
your readin
g
list?
Disco
v
er your ne
x
t
great read!
Get personalized book picks and up-to-date ne
w
s about this author.
Sign up no
w
.